IRCT20100127003210N15招募中3 期
Evaluation of Duloxetine effect on Oxaliplatin induced peripheral neuropathy prophylaxis
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Over 18 years old
- •The candidate patient is going to get his/her first chemotherapy course with Oxaliplatin drug
排除标准
- •The patient has no uncontrolled diabetes mellitus or uncontrolled hypertension
- •The patient is not taking drugs which have interaction with Duloxetin
- •The patient is not on liver metastatic stage
- •History of duloxetine allergy
- •hepatic impairment
- •clcr < 30ml/min and ESRD
研究者
相似试验
已完成
3 期
Prevention of Oxaliplatin Induced Peripheral Neuropathy (OIPN)Oxaliplatin Induced Peripheral Neuropathy (OIPN).Other anti neoplastic drugsIRCT20170211032494N2Tehran University of Medical Sciences46
已完成
1 期
Phase I/II study of the combination of Oxaliplatin and S-1 in patients with advanced/recurrent colorectal cancerunresectable advanced/recurrent colorectal cancerJPRN-C000000443Outpatient Oncology Unit Kyoto University Hospital42
进行中（未招募）
不适用
Phase I/II study of oxaliplatin combined with melphalan in isolated hepatic perfusion for the treatment of liver metastases. - Oxaliplatin combined with melphalan in IHP.EUCTR2006-005088-25-NLeiden University Medical Center
尚未招募
不适用
Phase I/II study of oxaliplatin combined with melphalan in isolated hepatic perfusion for the treatment of liver metastases.liver metastasessecondary liver tumours10017991NL-OMON30309eids Universitair Medisch Centrum60
已完成
2 期
Duloxetin for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients with depression.Colorectal cancerJPRN-UMIN000013969Kobe City Medical Center General Hospital25